Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Bitwise Ethereum ETFBitwise Ethereum ETF Reports Significant Asset Decline and Losses in Q1 2025
Atlanta Braves Holdings, Inc.Atlanta Braves Holdings Reports $47.2 Million Revenue in Q1 2025, Net Loss Improves
CF BANKSHARES INC.CF Bankshares Inc. Reports $4.4 Million Net Income for Q1 2025, Driven by 14.4% Rise in Net Interest Income
ArriVent Biopharma, Inc.ArriVent Biopharma Reports $64.4 Million Net Loss and Financial Challenges in Latest Quarter
Fox CorpFox Corporation Reports 27% Revenue Growth to $4.37 Billion in Latest Quarter
Comstock Holding Companies, Inc.Comstock Holding Companies Reports 18.8% Revenue Growth to $12.6 Million in Q1 2025
CervoMed Inc.CervoMed Reports $4.9 Million Net Loss in Q1 2025, Increased R&D Expenses
Vynleads, Inc.Vynleads Reports $80,970 Net Loss in Q1 2025, Seeks Additional Funding
BioXcel Therapeutics, Inc.BioXcel Therapeutics Reports $7.254 Million Net Loss and Decreased Product Revenue in Q1 2025
FORRESTER RESEARCH, INC.Forrester Research Reports 10% Revenue Decline and $87.3 Million Net Loss in Q1 2025
SONIDA SENIOR LIVING, INC.Sonida Senior Living Reports $13M Net Loss Despite 36.4% Revenue Increase in Latest Quarter
Centuri Holdings, Inc.Centuri Holdings Reports $550.1 Million Revenue with Improved Gross Profit but Net Loss in Latest Quarter
NOMAD POWER SOLUTIONS, INC.Lixte Biotechnology Reports Decreased Net Loss and Improved Cash Position for Q1 2025
1stdibs.com, Inc.1stdibs.com Reports 2% Revenue Growth to $22.5 Million in Q1 2025
UFP TECHNOLOGIES INCUFP Technologies Reports 41.1% Revenue Growth to $148.1 Million in Q1 2025
Imunon, Inc.Imunon Reports $4.1 Million Net Loss in Q1 2025, Decreased Operating Expenses
MBX Biosciences, Inc.MBX Biosciences Reports $23.9 Million Net Loss in Q1 2025, Increases R&D Spending
Solo Brands, Inc.Solo Brands Reports 9.5% Decline in Q1 2025 Net Sales, Net Loss Increases to $18.6 Million
UroGen Pharma Ltd.UroGen Pharma Reports $20.3 Million Revenue in Q1 2025, 7.8% Increase Year-Over-Year
Neuraxis, INCNeurAxis Reports Q1 2025 Financial Results with Increased Revenue but Higher Net Loss
Canton Strategic Holdings, Inc.Tharimmune Reports $2.54 Million Net Loss and Increased Operating Expenses for Q1 2025
YHN Acquisition I LtdYHN Acquisition I Limited Reports Q1 2025 Financial Results with Net Income Turnaround
Luduson G Inc.Luduson G Inc. Reports Revenue Drop to $0 and Net Loss of $3,524 in Q1 2025
Akero Therapeutics, Inc.Akero Therapeutics Reports $70.7 Million Net Loss in Q1 2025, Increases R&D Spending
ProMIS Neurosciences Inc.ProMIS Neurosciences Reports $7.3 Million Net Loss and Increased Operating Expenses for Q1 2025